A PHASE 2, RANDOMIZED, DOUBLE-BLIND, WITHIN-SUBJECT CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF EXC 001 FOR THE AMELIORATION OF SCARRING OF THE SURGICAL INCISION IN SUBJECTS UNDERGOING AN ELECTIVE ABDOMINOPLASTY
Latest Information Update: 06 Nov 2021
At a glance
- Drugs PF 6473871 (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Pfizer
Most Recent Events
- 08 May 2014 New trial record